RxDoctor Payments Data

Erik Nilssen, MD

Orthopaedic Surgery · Pensacola, FLNPI 1457579435

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $139,785 of the $211,523 with a category attached, or 66.1%. Zimmer Biomet accounts for 74.3% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $68,399 and has fallen 98.0% since, to $1,379 in 2025. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$211,523in general payments, 2019–2025

Across 126 payments — averaging $1678.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$157K
  • Globus Medical$25K
  • Curonix LLC$22K
  • Medartis Inc.$4K
  • Stimwave Technologies Incorporated$3K
  • Johnson & Johnson$173
  • plus $435 from 10 others
$250in research payments, 2019–2025

Across 1 payment — averaging $250.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Globus Medical$250

What the payments were for

  • Royalty or licence$139,78566%
  • Consulting fees$61,55729%
  • Speaking & faculty fees$4,0002%
  • Travel & lodging$4,4012%
  • Food & beverage$1,7811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$211,523 in reported general payments places this provider in the 90th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$340,253
Medicare patients
396
Services billed
2,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen125$1,773
Promethazine Hcl75$377
Celecoxib30$350
Pregabalin30$280
Tramadol Hcl32$155
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$54

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Pensacola

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →